Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Cancer Lett. 2011 Dec 13;318(1):106–113. doi: 10.1016/j.canlet.2011.12.008

Fig. 3.

Fig. 3

The Src specific inhibitor PP2 reduces c-Src and PKCι activities and suppresses cell migration and invasion induced by NNK. (A) and (B) H1299 cell were treated with NNK in the absence or presence of increasing concentrations of PP2 for 30 min. Activities of c-Src and PKCι were analyzed as described in “Methods”. (C) H1299 cells were treated with NNK in the absence or presence of increasing concentrations of PP2 for 24h. Cell migration and invasion were analyzed as the legend of figure 1E.